Mature dendritic cells can enhance CD8+ cell noncytotoxic anti-HIV responses: the role of IL-15

Blood. 2004 Apr 1;103(7):2699-704. doi: 10.1182/blood-2003-06-1913. Epub 2003 Dec 18.

Abstract

The CD8+ cell noncytotoxic anti-HIV response (CNAR) is associated with a long-term healthy clinical state in HIV-infected individuals. Over time CNAR is reduced concomitant with progression to disease. In studies to evaluate whether the interaction between CD8+ cells and dendritic cells (DCs) could increase CNAR, CD8+ cells from individuals who showed a decrease in this antiviral activity were cocultured with monocyte-derived dendritic cells matured with CD40 ligand. After coculture with these mature DCs, the CD8+ cells showed an increase in CNAR greater than that observed with CD8+ cells costimulated with CD3/CD28 antibodies. This antiviral response appeared to be mediated primarily by production of interleukin-15 (IL-15) by the mature DCs. Purified IL-15 also enhanced CNAR, whereas IL-12 showed no substantial effect. These studies provide another potential approach by which the immune system in HIV infection could be restored by cytokine therapy, particularly IL-15 administration.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • CD3 Complex / immunology
  • CD8 Antigens / immunology
  • CD8-Positive T-Lymphocytes / immunology*
  • Cytokines / immunology
  • Cytokines / therapeutic use
  • Cytotoxicity, Immunologic / immunology*
  • Dendritic Cells / immunology*
  • Disease Progression
  • HIV Infections / immunology*
  • Humans
  • Interleukin-15 / immunology*
  • Interleukin-15 / therapeutic use
  • Reference Values

Substances

  • CD3 Complex
  • CD8 Antigens
  • Cytokines
  • Interleukin-15